Clinical Trials

Colorectal Neoplasms

NCT03043950 2024-04-24

VALIDATE

Completed

647 enrolled

Colorectal Neoplasms

NCT00851136 2022-12-13

A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)

Phase 1 Completed

9 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00364013 2022-11-07

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

1,183 enrolled 18 charts

Neoplasms, Colorectal Neoplasms

NCT04145193 2020-09-21

Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC

Phase 2 Withdrawn

Colonic Neoplasms, Colorectal Neoplasms

NCT03035253 2020-08-11

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Phase 1 Terminated

16 enrolled

Colorectal Neoplasms

NCT00724503 2019-03-26

SIRFLOX

Phase NA Completed

530 enrolled 14 charts

Colonic Neoplasms, Colorectal Neoplasms

NCT00551213 2018-08-24

A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)

67 enrolled 12 charts

Colorectal Neoplasms

NCT03362684 2017-12-05

PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

1,808 enrolled

Colorectal Neoplasms

NCT01418222 2017-05-30

FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer

194 enrolled

Colorectal Neoplasms

NCT00384176 2017-04-14

HORIZON III

Phase 2/3 Completed

1,814 enrolled 13 charts

Colorectal Neoplasms

NCT00399035 2016-12-28

HORIZON II

1,254 enrolled 14 charts

Colorectal Neoplasms

NCT00873756 2016-11-02

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Phase 1 Completed

23 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT02202928 2015-12-28

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Phase 2 Unknown

60 enrolled

Digestive System Neoplasms, Gastrointestinal Diseases, Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

NCT00440310 2015-08-25

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

483 enrolled 7 charts

Liver Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

NCT00599924 2015-07-15

Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

Phase 1 Completed

53 enrolled 31 charts

Neoplasms, Colorectal Neoplasms

NCT00890305 2015-07-08

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

171 enrolled

Colorectal Neoplasms

NCT00778830 2015-05-14

APEC

Phase 1/2 Completed

289 enrolled 11 charts

Colorectal Neoplasms

NCT00959647 2015-01-07

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

DermatologicGastrointestinalGynecologic

19 enrolled 7 charts

Carcinoma, Basal Cell, Ovarian Neoplasms, Colorectal Neoplasms

NCT00494221 2014-03-27

A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

Phase 1/2 Completed

172 enrolled 12 charts

Neoplasm Metastasis, Colorectal Neoplasms

NCT00615056 2013-04-19

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

171 enrolled 13 charts

Colorectal Neoplasms

NCT00349336 2012-09-18

A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.

64 enrolled 15 charts

Colorectal Neoplasms

NCT00866944 2011-11-11

MT201-204

35 enrolled

Colorectal Neoplasms

NCT00478946 2009-01-21

A Study of Picoplatin in Colorectal Cancer

Phase 1/2 Unknown

43 enrolled